Placental Health and Pregnancy Outcomes

The placenta is a transient organ that orchestrates nutrient and gas exchange between mother and foetus while modulating immune tolerance and hormone production. Optimal placental development involves coordinated trophoblast invasion, spiral artery remodelling and angiogenesis; disruption of these processes may precipitate pre-eclampsia, fetal growth restriction, preterm birth and stillbirth. Vascular underdevelopment or excessive placental calcification can impair oxygen delivery, trigger oxidative stress and provoke systemic inflammation in the mother, heightening the risk of maternal cardiovascular sequelae and adverse perinatal outcomes. Advances in molecular profiling have identified gene signatures and immune cell patterns associated with placental dysfunction, while non-invasive monitoring technologies offer real-time assessment of oxygen saturation and hemodynamic parameters. Integrating biomarker panels, machine-learning algorithms and wearable sensors promises to refine risk stratification, enable earlier intervention and improve global maternal-foetal health, particularly in low-resource settings where standard surveillance remains limited.

Research from Nature Portfolio

Recent work has introduced an automated method for staging placental maturity on ultrasound images by combining dense feature extraction with a multi-layer Fisher vector encoding scheme. This approach yields high sensitivity and specificity in classifying placental developmental stages, reducing observer bias inherent in subjective grading. By leveraging machine-learning models trained on B-mode ultrasound data, the technique enhances reproducibility and may facilitate large-scale screening of placental ageing patterns that correlate with pregnancy complications.

Placental Health and Pregnancy Outcomes publication trend

The graph below shows the total number of articles in placental health and pregnancy outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Pre-eclampsia: A hypertensive disorder arising after 20 weeks’ gestation, characterised by new-onset hypertension and organ dysfunction or proteinuria.

Fetal growth restriction: A condition in which the fetus fails to achieve its genetically predetermined growth potential, often due to placental insufficiency.

Near-infrared spectroscopy (NIRS): A non-invasive optical technique for measuring tissue oxygen saturation by detecting absorption of near-infrared light.

Immune cell infiltration: The migration and accumulation of immune cells, such as macrophages and lymphocytes, into placental tissue, affecting inflammation and vascular remodelling.

Fisher vector encoding: A machine-learning feature representation that captures higher-order statistics of local descriptors for image classification tasks.

References

1. Integrated transcriptomic analysis and machine learning for characterizing diagnostic biomarkers and immune cell infiltration in fetal growth restriction. Frontiers in Immunology (2024).
2. A Wireless and Wearable Multimodal Sensor to Non-Invasively Monitor Transabdominal Placental Oxygen Saturation and Maternal Physiological Signals. Biosensors (2024).
3. Placental Tissue Calcification and Its Molecular Pathways in Female Patients with Late-Onset Preeclampsia. Biomolecules (2024).
4. Discriminative Learning for Automatic Staging of Placental Maturity via Multi-layer Fisher Vector. Scientific Reports (2015).
5. Placental Vascular Calcification and Cardiovascular Health: It Is Time to Determine How Much of Maternal and Offspring Health Is Written in Stone. Frontiers in Physiology (2018).